Global Opioids Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Opioids market size was valued at US$ 9831.4 million in 2023. With growing demand in downstream market, the Opioids is forecast to a readjusted size of US$ 14500 million by 2030 with a CAGR of 5.7% during review period.
The research report highlights the growth potential of the global Opioids market. Opioids are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Opioids. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Opioids market.
Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Opioids market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Opioids market. It may include historical data, market segmentation by Type (e.g., Oxycodone, Hydromorphone), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Opioids market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Opioids market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Opioids industry. This include advancements in Opioids technology, Opioids new entrants, Opioids new investment, and other innovations that are shaping the future of Opioids.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Opioids market. It includes factors influencing customer ' purchasing decisions, preferences for Opioids product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Opioids market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Opioids market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Opioids market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Opioids industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Opioids market.
Market Segmentation:
Opioids market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Opioids market?
What factors are driving Opioids market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Opioids market opportunities vary by end market size?
How does Opioids break out type, application?
According to our LPI (LP Information) latest study, the global Opioids market size was valued at US$ 9831.4 million in 2023. With growing demand in downstream market, the Opioids is forecast to a readjusted size of US$ 14500 million by 2030 with a CAGR of 5.7% during review period.
The research report highlights the growth potential of the global Opioids market. Opioids are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Opioids. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Opioids market.
Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Opioids market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Opioids market. It may include historical data, market segmentation by Type (e.g., Oxycodone, Hydromorphone), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Opioids market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Opioids market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Opioids industry. This include advancements in Opioids technology, Opioids new entrants, Opioids new investment, and other innovations that are shaping the future of Opioids.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Opioids market. It includes factors influencing customer ' purchasing decisions, preferences for Opioids product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Opioids market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Opioids market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Opioids market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Opioids industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Opioids market.
Market Segmentation:
Opioids market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Oxycodone
- Hydromorphone
- Codeine
- Fentanyl
- Other
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- Deaddiction
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Teva
- Purdue Pharma
- Mallinckrodt
- Amneal Pharma
- Collegium
- J&J
- Endo
- Pfizer
- INSYS
- Mylan
- Hikma
- Egalet
What is the 10-year outlook for the global Opioids market?
What factors are driving Opioids market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Opioids market opportunities vary by end market size?
How does Opioids break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Opioids Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Opioids by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Opioids by Country/Region, 2019, 2023 & 2030
2.2 Opioids Segment by Type
2.2.1 Oxycodone
2.2.2 Hydromorphone
2.2.3 Codeine
2.2.4 Fentanyl
2.2.5 Other
2.3 Opioids Sales by Type
2.3.1 Global Opioids Sales Market Share by Type (2019-2024)
2.3.2 Global Opioids Revenue and Market Share by Type (2019-2024)
2.3.3 Global Opioids Sale Price by Type (2019-2024)
2.4 Opioids Segment by Application
2.4.1 Pain Relief
2.4.2 Anesthesia
2.4.3 Cough Suppression
2.4.4 Diarrhea Suppression
2.4.5 Deaddiction
2.4.6 Others
2.5 Opioids Sales by Application
2.5.1 Global Opioids Sale Market Share by Application (2019-2024)
2.5.2 Global Opioids Revenue and Market Share by Application (2019-2024)
2.5.3 Global Opioids Sale Price by Application (2019-2024)
3 GLOBAL OPIOIDS BY COMPANY
3.1 Global Opioids Breakdown Data by Company
3.1.1 Global Opioids Annual Sales by Company (2019-2024)
3.1.2 Global Opioids Sales Market Share by Company (2019-2024)
3.2 Global Opioids Annual Revenue by Company (2019-2024)
3.2.1 Global Opioids Revenue by Company (2019-2024)
3.2.2 Global Opioids Revenue Market Share by Company (2019-2024)
3.3 Global Opioids Sale Price by Company
3.4 Key Manufacturers Opioids Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Opioids Product Location Distribution
3.4.2 Players Opioids Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR OPIOIDS BY GEOGRAPHIC REGION
4.1 World Historic Opioids Market Size by Geographic Region (2019-2024)
4.1.1 Global Opioids Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Opioids Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Opioids Market Size by Country/Region (2019-2024)
4.2.1 Global Opioids Annual Sales by Country/Region (2019-2024)
4.2.2 Global Opioids Annual Revenue by Country/Region (2019-2024)
4.3 Americas Opioids Sales Growth
4.4 APAC Opioids Sales Growth
4.5 Europe Opioids Sales Growth
4.6 Middle East & Africa Opioids Sales Growth
5 AMERICAS
5.1 Americas Opioids Sales by Country
5.1.1 Americas Opioids Sales by Country (2019-2024)
5.1.2 Americas Opioids Revenue by Country (2019-2024)
5.2 Americas Opioids Sales by Type
5.3 Americas Opioids Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Opioids Sales by Region
6.1.1 APAC Opioids Sales by Region (2019-2024)
6.1.2 APAC Opioids Revenue by Region (2019-2024)
6.2 APAC Opioids Sales by Type
6.3 APAC Opioids Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Opioids by Country
7.1.1 Europe Opioids Sales by Country (2019-2024)
7.1.2 Europe Opioids Revenue by Country (2019-2024)
7.2 Europe Opioids Sales by Type
7.3 Europe Opioids Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Opioids by Country
8.1.1 Middle East & Africa Opioids Sales by Country (2019-2024)
8.1.2 Middle East & Africa Opioids Revenue by Country (2019-2024)
8.2 Middle East & Africa Opioids Sales by Type
8.3 Middle East & Africa Opioids Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Opioids
10.3 Manufacturing Process Analysis of Opioids
10.4 Industry Chain Structure of Opioids
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Opioids Distributors
11.3 Opioids Customer
12 WORLD FORECAST REVIEW FOR OPIOIDS BY GEOGRAPHIC REGION
12.1 Global Opioids Market Size Forecast by Region
12.1.1 Global Opioids Forecast by Region (2025-2030)
12.1.2 Global Opioids Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Opioids Forecast by Type
12.7 Global Opioids Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Teva
13.1.1 Teva Company Information
13.1.2 Teva Opioids Product Portfolios and Specifications
13.1.3 Teva Opioids Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Teva Main Business Overview
13.1.5 Teva Latest Developments
13.2 Purdue Pharma
13.2.1 Purdue Pharma Company Information
13.2.2 Purdue Pharma Opioids Product Portfolios and Specifications
13.2.3 Purdue Pharma Opioids Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Purdue Pharma Main Business Overview
13.2.5 Purdue Pharma Latest Developments
13.3 Mallinckrodt
13.3.1 Mallinckrodt Company Information
13.3.2 Mallinckrodt Opioids Product Portfolios and Specifications
13.3.3 Mallinckrodt Opioids Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Mallinckrodt Main Business Overview
13.3.5 Mallinckrodt Latest Developments
13.4 Amneal Pharma
13.4.1 Amneal Pharma Company Information
13.4.2 Amneal Pharma Opioids Product Portfolios and Specifications
13.4.3 Amneal Pharma Opioids Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Amneal Pharma Main Business Overview
13.4.5 Amneal Pharma Latest Developments
13.5 Collegium
13.5.1 Collegium Company Information
13.5.2 Collegium Opioids Product Portfolios and Specifications
13.5.3 Collegium Opioids Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Collegium Main Business Overview
13.5.5 Collegium Latest Developments
13.6 J&J
13.6.1 J&J Company Information
13.6.2 J&J Opioids Product Portfolios and Specifications
13.6.3 J&J Opioids Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 J&J Main Business Overview
13.6.5 J&J Latest Developments
13.7 Endo
13.7.1 Endo Company Information
13.7.2 Endo Opioids Product Portfolios and Specifications
13.7.3 Endo Opioids Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Endo Main Business Overview
13.7.5 Endo Latest Developments
13.8 Pfizer
13.8.1 Pfizer Company Information
13.8.2 Pfizer Opioids Product Portfolios and Specifications
13.8.3 Pfizer Opioids Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Pfizer Main Business Overview
13.8.5 Pfizer Latest Developments
13.9 INSYS
13.9.1 INSYS Company Information
13.9.2 INSYS Opioids Product Portfolios and Specifications
13.9.3 INSYS Opioids Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 INSYS Main Business Overview
13.9.5 INSYS Latest Developments
13.10 Mylan
13.10.1 Mylan Company Information
13.10.2 Mylan Opioids Product Portfolios and Specifications
13.10.3 Mylan Opioids Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Mylan Main Business Overview
13.10.5 Mylan Latest Developments
13.11 Hikma
13.11.1 Hikma Company Information
13.11.2 Hikma Opioids Product Portfolios and Specifications
13.11.3 Hikma Opioids Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Hikma Main Business Overview
13.11.5 Hikma Latest Developments
13.12 Egalet
13.12.1 Egalet Company Information
13.12.2 Egalet Opioids Product Portfolios and Specifications
13.12.3 Egalet Opioids Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Egalet Main Business Overview
13.12.5 Egalet Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Opioids Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Opioids by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Opioids by Country/Region, 2019, 2023 & 2030
2.2 Opioids Segment by Type
2.2.1 Oxycodone
2.2.2 Hydromorphone
2.2.3 Codeine
2.2.4 Fentanyl
2.2.5 Other
2.3 Opioids Sales by Type
2.3.1 Global Opioids Sales Market Share by Type (2019-2024)
2.3.2 Global Opioids Revenue and Market Share by Type (2019-2024)
2.3.3 Global Opioids Sale Price by Type (2019-2024)
2.4 Opioids Segment by Application
2.4.1 Pain Relief
2.4.2 Anesthesia
2.4.3 Cough Suppression
2.4.4 Diarrhea Suppression
2.4.5 Deaddiction
2.4.6 Others
2.5 Opioids Sales by Application
2.5.1 Global Opioids Sale Market Share by Application (2019-2024)
2.5.2 Global Opioids Revenue and Market Share by Application (2019-2024)
2.5.3 Global Opioids Sale Price by Application (2019-2024)
3 GLOBAL OPIOIDS BY COMPANY
3.1 Global Opioids Breakdown Data by Company
3.1.1 Global Opioids Annual Sales by Company (2019-2024)
3.1.2 Global Opioids Sales Market Share by Company (2019-2024)
3.2 Global Opioids Annual Revenue by Company (2019-2024)
3.2.1 Global Opioids Revenue by Company (2019-2024)
3.2.2 Global Opioids Revenue Market Share by Company (2019-2024)
3.3 Global Opioids Sale Price by Company
3.4 Key Manufacturers Opioids Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Opioids Product Location Distribution
3.4.2 Players Opioids Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR OPIOIDS BY GEOGRAPHIC REGION
4.1 World Historic Opioids Market Size by Geographic Region (2019-2024)
4.1.1 Global Opioids Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Opioids Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Opioids Market Size by Country/Region (2019-2024)
4.2.1 Global Opioids Annual Sales by Country/Region (2019-2024)
4.2.2 Global Opioids Annual Revenue by Country/Region (2019-2024)
4.3 Americas Opioids Sales Growth
4.4 APAC Opioids Sales Growth
4.5 Europe Opioids Sales Growth
4.6 Middle East & Africa Opioids Sales Growth
5 AMERICAS
5.1 Americas Opioids Sales by Country
5.1.1 Americas Opioids Sales by Country (2019-2024)
5.1.2 Americas Opioids Revenue by Country (2019-2024)
5.2 Americas Opioids Sales by Type
5.3 Americas Opioids Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Opioids Sales by Region
6.1.1 APAC Opioids Sales by Region (2019-2024)
6.1.2 APAC Opioids Revenue by Region (2019-2024)
6.2 APAC Opioids Sales by Type
6.3 APAC Opioids Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Opioids by Country
7.1.1 Europe Opioids Sales by Country (2019-2024)
7.1.2 Europe Opioids Revenue by Country (2019-2024)
7.2 Europe Opioids Sales by Type
7.3 Europe Opioids Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Opioids by Country
8.1.1 Middle East & Africa Opioids Sales by Country (2019-2024)
8.1.2 Middle East & Africa Opioids Revenue by Country (2019-2024)
8.2 Middle East & Africa Opioids Sales by Type
8.3 Middle East & Africa Opioids Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Opioids
10.3 Manufacturing Process Analysis of Opioids
10.4 Industry Chain Structure of Opioids
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Opioids Distributors
11.3 Opioids Customer
12 WORLD FORECAST REVIEW FOR OPIOIDS BY GEOGRAPHIC REGION
12.1 Global Opioids Market Size Forecast by Region
12.1.1 Global Opioids Forecast by Region (2025-2030)
12.1.2 Global Opioids Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Opioids Forecast by Type
12.7 Global Opioids Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Teva
13.1.1 Teva Company Information
13.1.2 Teva Opioids Product Portfolios and Specifications
13.1.3 Teva Opioids Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Teva Main Business Overview
13.1.5 Teva Latest Developments
13.2 Purdue Pharma
13.2.1 Purdue Pharma Company Information
13.2.2 Purdue Pharma Opioids Product Portfolios and Specifications
13.2.3 Purdue Pharma Opioids Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Purdue Pharma Main Business Overview
13.2.5 Purdue Pharma Latest Developments
13.3 Mallinckrodt
13.3.1 Mallinckrodt Company Information
13.3.2 Mallinckrodt Opioids Product Portfolios and Specifications
13.3.3 Mallinckrodt Opioids Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Mallinckrodt Main Business Overview
13.3.5 Mallinckrodt Latest Developments
13.4 Amneal Pharma
13.4.1 Amneal Pharma Company Information
13.4.2 Amneal Pharma Opioids Product Portfolios and Specifications
13.4.3 Amneal Pharma Opioids Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Amneal Pharma Main Business Overview
13.4.5 Amneal Pharma Latest Developments
13.5 Collegium
13.5.1 Collegium Company Information
13.5.2 Collegium Opioids Product Portfolios and Specifications
13.5.3 Collegium Opioids Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Collegium Main Business Overview
13.5.5 Collegium Latest Developments
13.6 J&J
13.6.1 J&J Company Information
13.6.2 J&J Opioids Product Portfolios and Specifications
13.6.3 J&J Opioids Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 J&J Main Business Overview
13.6.5 J&J Latest Developments
13.7 Endo
13.7.1 Endo Company Information
13.7.2 Endo Opioids Product Portfolios and Specifications
13.7.3 Endo Opioids Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Endo Main Business Overview
13.7.5 Endo Latest Developments
13.8 Pfizer
13.8.1 Pfizer Company Information
13.8.2 Pfizer Opioids Product Portfolios and Specifications
13.8.3 Pfizer Opioids Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Pfizer Main Business Overview
13.8.5 Pfizer Latest Developments
13.9 INSYS
13.9.1 INSYS Company Information
13.9.2 INSYS Opioids Product Portfolios and Specifications
13.9.3 INSYS Opioids Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 INSYS Main Business Overview
13.9.5 INSYS Latest Developments
13.10 Mylan
13.10.1 Mylan Company Information
13.10.2 Mylan Opioids Product Portfolios and Specifications
13.10.3 Mylan Opioids Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Mylan Main Business Overview
13.10.5 Mylan Latest Developments
13.11 Hikma
13.11.1 Hikma Company Information
13.11.2 Hikma Opioids Product Portfolios and Specifications
13.11.3 Hikma Opioids Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Hikma Main Business Overview
13.11.5 Hikma Latest Developments
13.12 Egalet
13.12.1 Egalet Company Information
13.12.2 Egalet Opioids Product Portfolios and Specifications
13.12.3 Egalet Opioids Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Egalet Main Business Overview
13.12.5 Egalet Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Opioids Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Opioids Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Oxycodone
Table 4. Major Players of Hydromorphone
Table 5. Major Players of Codeine
Table 6. Major Players of Fentanyl
Table 7. Major Players of Other
Table 8. Global Opioids Sales by Type (2019-2024) & (MT)
Table 9. Global Opioids Sales Market Share by Type (2019-2024)
Table 10. Global Opioids Revenue by Type (2019-2024) & ($ million)
Table 11. Global Opioids Revenue Market Share by Type (2019-2024)
Table 12. Global Opioids Sale Price by Type (2019-2024) & (USD/Kg)
Table 13. Global Opioids Sales by Application (2019-2024) & (MT)
Table 14. Global Opioids Sales Market Share by Application (2019-2024)
Table 15. Global Opioids Revenue by Application (2019-2024)
Table 16. Global Opioids Revenue Market Share by Application (2019-2024)
Table 17. Global Opioids Sale Price by Application (2019-2024) & (USD/Kg)
Table 18. Global Opioids Sales by Company (2019-2024) & (MT)
Table 19. Global Opioids Sales Market Share by Company (2019-2024)
Table 20. Global Opioids Revenue by Company (2019-2024) ($ Millions)
Table 21. Global Opioids Revenue Market Share by Company (2019-2024)
Table 22. Global Opioids Sale Price by Company (2019-2024) & (USD/Kg)
Table 23. Key Manufacturers Opioids Producing Area Distribution and Sales Area
Table 24. Players Opioids Products Offered
Table 25. Opioids Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Opioids Sales by Geographic Region (2019-2024) & (MT)
Table 29. Global Opioids Sales Market Share Geographic Region (2019-2024)
Table 30. Global Opioids Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Opioids Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Opioids Sales by Country/Region (2019-2024) & (MT)
Table 33. Global Opioids Sales Market Share by Country/Region (2019-2024)
Table 34. Global Opioids Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Opioids Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Opioids Sales by Country (2019-2024) & (MT)
Table 37. Americas Opioids Sales Market Share by Country (2019-2024)
Table 38. Americas Opioids Revenue by Country (2019-2024) & ($ Millions)
Table 39. Americas Opioids Revenue Market Share by Country (2019-2024)
Table 40. Americas Opioids Sales by Type (2019-2024) & (MT)
Table 41. Americas Opioids Sales by Application (2019-2024) & (MT)
Table 42. APAC Opioids Sales by Region (2019-2024) & (MT)
Table 43. APAC Opioids Sales Market Share by Region (2019-2024)
Table 44. APAC Opioids Revenue by Region (2019-2024) & ($ Millions)
Table 45. APAC Opioids Revenue Market Share by Region (2019-2024)
Table 46. APAC Opioids Sales by Type (2019-2024) & (MT)
Table 47. APAC Opioids Sales by Application (2019-2024) & (MT)
Table 48. Europe Opioids Sales by Country (2019-2024) & (MT)
Table 49. Europe Opioids Sales Market Share by Country (2019-2024)
Table 50. Europe Opioids Revenue by Country (2019-2024) & ($ Millions)
Table 51. Europe Opioids Revenue Market Share by Country (2019-2024)
Table 52. Europe Opioids Sales by Type (2019-2024) & (MT)
Table 53. Europe Opioids Sales by Application (2019-2024) & (MT)
Table 54. Middle East & Africa Opioids Sales by Country (2019-2024) & (MT)
Table 55. Middle East & Africa Opioids Sales Market Share by Country (2019-2024)
Table 56. Middle East & Africa Opioids Revenue by Country (2019-2024) & ($ Millions)
Table 57. Middle East & Africa Opioids Revenue Market Share by Country (2019-2024)
Table 58. Middle East & Africa Opioids Sales by Type (2019-2024) & (MT)
Table 59. Middle East & Africa Opioids Sales by Application (2019-2024) & (MT)
Table 60. Key Market Drivers & Growth Opportunities of Opioids
Table 61. Key Market Challenges & Risks of Opioids
Table 62. Key Industry Trends of Opioids
Table 63. Opioids Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Opioids Distributors List
Table 66. Opioids Customer List
Table 67. Global Opioids Sales Forecast by Region (2025-2030) & (MT)
Table 68. Global Opioids Revenue Forecast by Region (2025-2030) & ($ millions)
Table 69. Americas Opioids Sales Forecast by Country (2025-2030) & (MT)
Table 70. Americas Opioids Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. APAC Opioids Sales Forecast by Region (2025-2030) & (MT)
Table 72. APAC Opioids Revenue Forecast by Region (2025-2030) & ($ millions)
Table 73. Europe Opioids Sales Forecast by Country (2025-2030) & (MT)
Table 74. Europe Opioids Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Middle East & Africa Opioids Sales Forecast by Country (2025-2030) & (MT)
Table 76. Middle East & Africa Opioids Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Global Opioids Sales Forecast by Type (2025-2030) & (MT)
Table 78. Global Opioids Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 79. Global Opioids Sales Forecast by Application (2025-2030) & (MT)
Table 80. Global Opioids Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 81. Teva Basic Information, Opioids Manufacturing Base, Sales Area and Its Competitors
Table 82. Teva Opioids Product Portfolios and Specifications
Table 83. Teva Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 84. Teva Main Business
Table 85. Teva Latest Developments
Table 86. Purdue Pharma Basic Information, Opioids Manufacturing Base, Sales Area and Its Competitors
Table 87. Purdue Pharma Opioids Product Portfolios and Specifications
Table 88. Purdue Pharma Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 89. Purdue Pharma Main Business
Table 90. Purdue Pharma Latest Developments
Table 91. Mallinckrodt Basic Information, Opioids Manufacturing Base, Sales Area and Its Competitors
Table 92. Mallinckrodt Opioids Product Portfolios and Specifications
Table 93. Mallinckrodt Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 94. Mallinckrodt Main Business
Table 95. Mallinckrodt Latest Developments
Table 96. Amneal Pharma Basic Information, Opioids Manufacturing Base, Sales Area and Its Competitors
Table 97. Amneal Pharma Opioids Product Portfolios and Specifications
Table 98. Amneal Pharma Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 99. Amneal Pharma Main Business
Table 100. Amneal Pharma Latest Developments
Table 101. Collegium Basic Information, Opioids Manufacturing Base, Sales Area and Its Competitors
Table 102. Collegium Opioids Product Portfolios and Specifications
Table 103. Collegium Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 104. Collegium Main Business
Table 105. Collegium Latest Developments
Table 106. J&J Basic Information, Opioids Manufacturing Base, Sales Area and Its Competitors
Table 107. J&J Opioids Product Portfolios and Specifications
Table 108. J&J Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 109. J&J Main Business
Table 110. J&J Latest Developments
Table 111. Endo Basic Information, Opioids Manufacturing Base, Sales Area and Its Competitors
Table 112. Endo Opioids Product Portfolios and Specifications
Table 113. Endo Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 114. Endo Main Business
Table 115. Endo Latest Developments
Table 116. Pfizer Basic Information, Opioids Manufacturing Base, Sales Area and Its Competitors
Table 117. Pfizer Opioids Product Portfolios and Specifications
Table 118. Pfizer Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 119. Pfizer Main Business
Table 120. Pfizer Latest Developments
Table 121. INSYS Basic Information, Opioids Manufacturing Base, Sales Area and Its Competitors
Table 122. INSYS Opioids Product Portfolios and Specifications
Table 123. INSYS Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 124. INSYS Main Business
Table 125. INSYS Latest Developments
Table 126. Mylan Basic Information, Opioids Manufacturing Base, Sales Area and Its Competitors
Table 127. Mylan Opioids Product Portfolios and Specifications
Table 128. Mylan Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 129. Mylan Main Business
Table 130. Mylan Latest Developments
Table 131. Hikma Basic Information, Opioids Manufacturing Base, Sales Area and Its Competitors
Table 132. Hikma Opioids Product Portfolios and Specifications
Table 133. Hikma Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 134. Hikma Main Business
Table 135. Hikma Latest Developments
Table 136. Egalet Basic Information, Opioids Manufacturing Base, Sales Area and Its Competitors
Table 137. Egalet Opioids Product Portfolios and Specifications
Table 138. Egalet Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 139. Egalet Main Business
Table 140. Egalet Latest Developments
Table 1. Opioids Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Opioids Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Oxycodone
Table 4. Major Players of Hydromorphone
Table 5. Major Players of Codeine
Table 6. Major Players of Fentanyl
Table 7. Major Players of Other
Table 8. Global Opioids Sales by Type (2019-2024) & (MT)
Table 9. Global Opioids Sales Market Share by Type (2019-2024)
Table 10. Global Opioids Revenue by Type (2019-2024) & ($ million)
Table 11. Global Opioids Revenue Market Share by Type (2019-2024)
Table 12. Global Opioids Sale Price by Type (2019-2024) & (USD/Kg)
Table 13. Global Opioids Sales by Application (2019-2024) & (MT)
Table 14. Global Opioids Sales Market Share by Application (2019-2024)
Table 15. Global Opioids Revenue by Application (2019-2024)
Table 16. Global Opioids Revenue Market Share by Application (2019-2024)
Table 17. Global Opioids Sale Price by Application (2019-2024) & (USD/Kg)
Table 18. Global Opioids Sales by Company (2019-2024) & (MT)
Table 19. Global Opioids Sales Market Share by Company (2019-2024)
Table 20. Global Opioids Revenue by Company (2019-2024) ($ Millions)
Table 21. Global Opioids Revenue Market Share by Company (2019-2024)
Table 22. Global Opioids Sale Price by Company (2019-2024) & (USD/Kg)
Table 23. Key Manufacturers Opioids Producing Area Distribution and Sales Area
Table 24. Players Opioids Products Offered
Table 25. Opioids Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Opioids Sales by Geographic Region (2019-2024) & (MT)
Table 29. Global Opioids Sales Market Share Geographic Region (2019-2024)
Table 30. Global Opioids Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Opioids Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Opioids Sales by Country/Region (2019-2024) & (MT)
Table 33. Global Opioids Sales Market Share by Country/Region (2019-2024)
Table 34. Global Opioids Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Opioids Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Opioids Sales by Country (2019-2024) & (MT)
Table 37. Americas Opioids Sales Market Share by Country (2019-2024)
Table 38. Americas Opioids Revenue by Country (2019-2024) & ($ Millions)
Table 39. Americas Opioids Revenue Market Share by Country (2019-2024)
Table 40. Americas Opioids Sales by Type (2019-2024) & (MT)
Table 41. Americas Opioids Sales by Application (2019-2024) & (MT)
Table 42. APAC Opioids Sales by Region (2019-2024) & (MT)
Table 43. APAC Opioids Sales Market Share by Region (2019-2024)
Table 44. APAC Opioids Revenue by Region (2019-2024) & ($ Millions)
Table 45. APAC Opioids Revenue Market Share by Region (2019-2024)
Table 46. APAC Opioids Sales by Type (2019-2024) & (MT)
Table 47. APAC Opioids Sales by Application (2019-2024) & (MT)
Table 48. Europe Opioids Sales by Country (2019-2024) & (MT)
Table 49. Europe Opioids Sales Market Share by Country (2019-2024)
Table 50. Europe Opioids Revenue by Country (2019-2024) & ($ Millions)
Table 51. Europe Opioids Revenue Market Share by Country (2019-2024)
Table 52. Europe Opioids Sales by Type (2019-2024) & (MT)
Table 53. Europe Opioids Sales by Application (2019-2024) & (MT)
Table 54. Middle East & Africa Opioids Sales by Country (2019-2024) & (MT)
Table 55. Middle East & Africa Opioids Sales Market Share by Country (2019-2024)
Table 56. Middle East & Africa Opioids Revenue by Country (2019-2024) & ($ Millions)
Table 57. Middle East & Africa Opioids Revenue Market Share by Country (2019-2024)
Table 58. Middle East & Africa Opioids Sales by Type (2019-2024) & (MT)
Table 59. Middle East & Africa Opioids Sales by Application (2019-2024) & (MT)
Table 60. Key Market Drivers & Growth Opportunities of Opioids
Table 61. Key Market Challenges & Risks of Opioids
Table 62. Key Industry Trends of Opioids
Table 63. Opioids Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Opioids Distributors List
Table 66. Opioids Customer List
Table 67. Global Opioids Sales Forecast by Region (2025-2030) & (MT)
Table 68. Global Opioids Revenue Forecast by Region (2025-2030) & ($ millions)
Table 69. Americas Opioids Sales Forecast by Country (2025-2030) & (MT)
Table 70. Americas Opioids Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. APAC Opioids Sales Forecast by Region (2025-2030) & (MT)
Table 72. APAC Opioids Revenue Forecast by Region (2025-2030) & ($ millions)
Table 73. Europe Opioids Sales Forecast by Country (2025-2030) & (MT)
Table 74. Europe Opioids Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Middle East & Africa Opioids Sales Forecast by Country (2025-2030) & (MT)
Table 76. Middle East & Africa Opioids Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Global Opioids Sales Forecast by Type (2025-2030) & (MT)
Table 78. Global Opioids Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 79. Global Opioids Sales Forecast by Application (2025-2030) & (MT)
Table 80. Global Opioids Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 81. Teva Basic Information, Opioids Manufacturing Base, Sales Area and Its Competitors
Table 82. Teva Opioids Product Portfolios and Specifications
Table 83. Teva Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 84. Teva Main Business
Table 85. Teva Latest Developments
Table 86. Purdue Pharma Basic Information, Opioids Manufacturing Base, Sales Area and Its Competitors
Table 87. Purdue Pharma Opioids Product Portfolios and Specifications
Table 88. Purdue Pharma Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 89. Purdue Pharma Main Business
Table 90. Purdue Pharma Latest Developments
Table 91. Mallinckrodt Basic Information, Opioids Manufacturing Base, Sales Area and Its Competitors
Table 92. Mallinckrodt Opioids Product Portfolios and Specifications
Table 93. Mallinckrodt Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 94. Mallinckrodt Main Business
Table 95. Mallinckrodt Latest Developments
Table 96. Amneal Pharma Basic Information, Opioids Manufacturing Base, Sales Area and Its Competitors
Table 97. Amneal Pharma Opioids Product Portfolios and Specifications
Table 98. Amneal Pharma Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 99. Amneal Pharma Main Business
Table 100. Amneal Pharma Latest Developments
Table 101. Collegium Basic Information, Opioids Manufacturing Base, Sales Area and Its Competitors
Table 102. Collegium Opioids Product Portfolios and Specifications
Table 103. Collegium Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 104. Collegium Main Business
Table 105. Collegium Latest Developments
Table 106. J&J Basic Information, Opioids Manufacturing Base, Sales Area and Its Competitors
Table 107. J&J Opioids Product Portfolios and Specifications
Table 108. J&J Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 109. J&J Main Business
Table 110. J&J Latest Developments
Table 111. Endo Basic Information, Opioids Manufacturing Base, Sales Area and Its Competitors
Table 112. Endo Opioids Product Portfolios and Specifications
Table 113. Endo Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 114. Endo Main Business
Table 115. Endo Latest Developments
Table 116. Pfizer Basic Information, Opioids Manufacturing Base, Sales Area and Its Competitors
Table 117. Pfizer Opioids Product Portfolios and Specifications
Table 118. Pfizer Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 119. Pfizer Main Business
Table 120. Pfizer Latest Developments
Table 121. INSYS Basic Information, Opioids Manufacturing Base, Sales Area and Its Competitors
Table 122. INSYS Opioids Product Portfolios and Specifications
Table 123. INSYS Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 124. INSYS Main Business
Table 125. INSYS Latest Developments
Table 126. Mylan Basic Information, Opioids Manufacturing Base, Sales Area and Its Competitors
Table 127. Mylan Opioids Product Portfolios and Specifications
Table 128. Mylan Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 129. Mylan Main Business
Table 130. Mylan Latest Developments
Table 131. Hikma Basic Information, Opioids Manufacturing Base, Sales Area and Its Competitors
Table 132. Hikma Opioids Product Portfolios and Specifications
Table 133. Hikma Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 134. Hikma Main Business
Table 135. Hikma Latest Developments
Table 136. Egalet Basic Information, Opioids Manufacturing Base, Sales Area and Its Competitors
Table 137. Egalet Opioids Product Portfolios and Specifications
Table 138. Egalet Opioids Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 139. Egalet Main Business
Table 140. Egalet Latest Developments
LIST OF FIGURES
Figure 1. Picture of Opioids
Figure 2. Opioids Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Opioids Sales Growth Rate 2019-2030 (MT)
Figure 7. Global Opioids Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Opioids Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Oxycodone
Figure 10. Product Picture of Hydromorphone
Figure 11. Product Picture of Codeine
Figure 12. Product Picture of Fentanyl
Figure 13. Product Picture of Other
Figure 14. Global Opioids Sales Market Share by Type in 2023
Figure 15. Global Opioids Revenue Market Share by Type (2019-2024)
Figure 16. Opioids Consumed in Pain Relief
Figure 17. Global Opioids Market: Pain Relief (2019-2024) & (MT)
Figure 18. Opioids Consumed in Anesthesia
Figure 19. Global Opioids Market: Anesthesia (2019-2024) & (MT)
Figure 20. Opioids Consumed in Cough Suppression
Figure 21. Global Opioids Market: Cough Suppression (2019-2024) & (MT)
Figure 22. Opioids Consumed in Diarrhea Suppression
Figure 23. Global Opioids Market: Diarrhea Suppression (2019-2024) & (MT)
Figure 24. Opioids Consumed in Deaddiction
Figure 25. Global Opioids Market: Deaddiction (2019-2024) & (MT)
Figure 26. Opioids Consumed in Others
Figure 27. Global Opioids Market: Others (2019-2024) & (MT)
Figure 28. Global Opioids Sales Market Share by Application (2023)
Figure 29. Global Opioids Revenue Market Share by Application in 2023
Figure 30. Opioids Sales Market by Company in 2023 (MT)
Figure 31. Global Opioids Sales Market Share by Company in 2023
Figure 32. Opioids Revenue Market by Company in 2023 ($ Million)
Figure 33. Global Opioids Revenue Market Share by Company in 2023
Figure 34. Global Opioids Sales Market Share by Geographic Region (2019-2024)
Figure 35. Global Opioids Revenue Market Share by Geographic Region in 2023
Figure 36. Americas Opioids Sales 2019-2024 (MT)
Figure 37. Americas Opioids Revenue 2019-2024 ($ Millions)
Figure 38. APAC Opioids Sales 2019-2024 (MT)
Figure 39. APAC Opioids Revenue 2019-2024 ($ Millions)
Figure 40. Europe Opioids Sales 2019-2024 (MT)
Figure 41. Europe Opioids Revenue 2019-2024 ($ Millions)
Figure 42. Middle East & Africa Opioids Sales 2019-2024 (MT)
Figure 43. Middle East & Africa Opioids Revenue 2019-2024 ($ Millions)
Figure 44. Americas Opioids Sales Market Share by Country in 2023
Figure 45. Americas Opioids Revenue Market Share by Country in 2023
Figure 46. Americas Opioids Sales Market Share by Type (2019-2024)
Figure 47. Americas Opioids Sales Market Share by Application (2019-2024)
Figure 48. United States Opioids Revenue Growth 2019-2024 ($ Millions)
Figure 49. Canada Opioids Revenue Growth 2019-2024 ($ Millions)
Figure 50. Mexico Opioids Revenue Growth 2019-2024 ($ Millions)
Figure 51. Brazil Opioids Revenue Growth 2019-2024 ($ Millions)
Figure 52. APAC Opioids Sales Market Share by Region in 2023
Figure 53. APAC Opioids Revenue Market Share by Regions in 2023
Figure 54. APAC Opioids Sales Market Share by Type (2019-2024)
Figure 55. APAC Opioids Sales Market Share by Application (2019-2024)
Figure 56. China Opioids Revenue Growth 2019-2024 ($ Millions)
Figure 57. Japan Opioids Revenue Growth 2019-2024 ($ Millions)
Figure 58. South Korea Opioids Revenue Growth 2019-2024 ($ Millions)
Figure 59. Southeast Asia Opioids Revenue Growth 2019-2024 ($ Millions)
Figure 60. India Opioids Revenue Growth 2019-2024 ($ Millions)
Figure 61. Australia Opioids Revenue Growth 2019-2024 ($ Millions)
Figure 62. China Taiwan Opioids Revenue Growth 2019-2024 ($ Millions)
Figure 63. Europe Opioids Sales Market Share by Country in 2023
Figure 64. Europe Opioids Revenue Market Share by Country in 2023
Figure 65. Europe Opioids Sales Market Share by Type (2019-2024)
Figure 66. Europe Opioids Sales Market Share by Application (2019-2024)
Figure 67. Germany Opioids Revenue Growth 2019-2024 ($ Millions)
Figure 68. France Opioids Revenue Growth 2019-2024 ($ Millions)
Figure 69. UK Opioids Revenue Growth 2019-2024 ($ Millions)
Figure 70. Italy Opioids Revenue Growth 2019-2024 ($ Millions)
Figure 71. Russia Opioids Revenue Growth 2019-2024 ($ Millions)
Figure 72. Middle East & Africa Opioids Sales Market Share by Country in 2023
Figure 73. Middle East & Africa Opioids Revenue Market Share by Country in 2023
Figure 74. Middle East & Africa Opioids Sales Market Share by Type (2019-2024)
Figure 75. Middle East & Africa Opioids Sales Market Share by Application (2019-2024)
Figure 76. Egypt Opioids Revenue Growth 2019-2024 ($ Millions)
Figure 77. South Africa Opioids Revenue Growth 2019-2024 ($ Millions)
Figure 78. Israel Opioids Revenue Growth 2019-2024 ($ Millions)
Figure 79. Turkey Opioids Revenue Growth 2019-2024 ($ Millions)
Figure 80. GCC Country Opioids Revenue Growth 2019-2024 ($ Millions)
Figure 81. Manufacturing Cost Structure Analysis of Opioids in 2023
Figure 82. Manufacturing Process Analysis of Opioids
Figure 83. Industry Chain Structure of Opioids
Figure 84. Channels of Distribution
Figure 85. Global Opioids Sales Market Forecast by Region (2025-2030)
Figure 86. Global Opioids Revenue Market Share Forecast by Region (2025-2030)
Figure 87. Global Opioids Sales Market Share Forecast by Type (2025-2030)
Figure 88. Global Opioids Revenue Market Share Forecast by Type (2025-2030)
Figure 89. Global Opioids Sales Market Share Forecast by Application (2025-2030)
Figure 90. Global Opioids Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Opioids
Figure 2. Opioids Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Opioids Sales Growth Rate 2019-2030 (MT)
Figure 7. Global Opioids Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Opioids Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Oxycodone
Figure 10. Product Picture of Hydromorphone
Figure 11. Product Picture of Codeine
Figure 12. Product Picture of Fentanyl
Figure 13. Product Picture of Other
Figure 14. Global Opioids Sales Market Share by Type in 2023
Figure 15. Global Opioids Revenue Market Share by Type (2019-2024)
Figure 16. Opioids Consumed in Pain Relief
Figure 17. Global Opioids Market: Pain Relief (2019-2024) & (MT)
Figure 18. Opioids Consumed in Anesthesia
Figure 19. Global Opioids Market: Anesthesia (2019-2024) & (MT)
Figure 20. Opioids Consumed in Cough Suppression
Figure 21. Global Opioids Market: Cough Suppression (2019-2024) & (MT)
Figure 22. Opioids Consumed in Diarrhea Suppression
Figure 23. Global Opioids Market: Diarrhea Suppression (2019-2024) & (MT)
Figure 24. Opioids Consumed in Deaddiction
Figure 25. Global Opioids Market: Deaddiction (2019-2024) & (MT)
Figure 26. Opioids Consumed in Others
Figure 27. Global Opioids Market: Others (2019-2024) & (MT)
Figure 28. Global Opioids Sales Market Share by Application (2023)
Figure 29. Global Opioids Revenue Market Share by Application in 2023
Figure 30. Opioids Sales Market by Company in 2023 (MT)
Figure 31. Global Opioids Sales Market Share by Company in 2023
Figure 32. Opioids Revenue Market by Company in 2023 ($ Million)
Figure 33. Global Opioids Revenue Market Share by Company in 2023
Figure 34. Global Opioids Sales Market Share by Geographic Region (2019-2024)
Figure 35. Global Opioids Revenue Market Share by Geographic Region in 2023
Figure 36. Americas Opioids Sales 2019-2024 (MT)
Figure 37. Americas Opioids Revenue 2019-2024 ($ Millions)
Figure 38. APAC Opioids Sales 2019-2024 (MT)
Figure 39. APAC Opioids Revenue 2019-2024 ($ Millions)
Figure 40. Europe Opioids Sales 2019-2024 (MT)
Figure 41. Europe Opioids Revenue 2019-2024 ($ Millions)
Figure 42. Middle East & Africa Opioids Sales 2019-2024 (MT)
Figure 43. Middle East & Africa Opioids Revenue 2019-2024 ($ Millions)
Figure 44. Americas Opioids Sales Market Share by Country in 2023
Figure 45. Americas Opioids Revenue Market Share by Country in 2023
Figure 46. Americas Opioids Sales Market Share by Type (2019-2024)
Figure 47. Americas Opioids Sales Market Share by Application (2019-2024)
Figure 48. United States Opioids Revenue Growth 2019-2024 ($ Millions)
Figure 49. Canada Opioids Revenue Growth 2019-2024 ($ Millions)
Figure 50. Mexico Opioids Revenue Growth 2019-2024 ($ Millions)
Figure 51. Brazil Opioids Revenue Growth 2019-2024 ($ Millions)
Figure 52. APAC Opioids Sales Market Share by Region in 2023
Figure 53. APAC Opioids Revenue Market Share by Regions in 2023
Figure 54. APAC Opioids Sales Market Share by Type (2019-2024)
Figure 55. APAC Opioids Sales Market Share by Application (2019-2024)
Figure 56. China Opioids Revenue Growth 2019-2024 ($ Millions)
Figure 57. Japan Opioids Revenue Growth 2019-2024 ($ Millions)
Figure 58. South Korea Opioids Revenue Growth 2019-2024 ($ Millions)
Figure 59. Southeast Asia Opioids Revenue Growth 2019-2024 ($ Millions)
Figure 60. India Opioids Revenue Growth 2019-2024 ($ Millions)
Figure 61. Australia Opioids Revenue Growth 2019-2024 ($ Millions)
Figure 62. China Taiwan Opioids Revenue Growth 2019-2024 ($ Millions)
Figure 63. Europe Opioids Sales Market Share by Country in 2023
Figure 64. Europe Opioids Revenue Market Share by Country in 2023
Figure 65. Europe Opioids Sales Market Share by Type (2019-2024)
Figure 66. Europe Opioids Sales Market Share by Application (2019-2024)
Figure 67. Germany Opioids Revenue Growth 2019-2024 ($ Millions)
Figure 68. France Opioids Revenue Growth 2019-2024 ($ Millions)
Figure 69. UK Opioids Revenue Growth 2019-2024 ($ Millions)
Figure 70. Italy Opioids Revenue Growth 2019-2024 ($ Millions)
Figure 71. Russia Opioids Revenue Growth 2019-2024 ($ Millions)
Figure 72. Middle East & Africa Opioids Sales Market Share by Country in 2023
Figure 73. Middle East & Africa Opioids Revenue Market Share by Country in 2023
Figure 74. Middle East & Africa Opioids Sales Market Share by Type (2019-2024)
Figure 75. Middle East & Africa Opioids Sales Market Share by Application (2019-2024)
Figure 76. Egypt Opioids Revenue Growth 2019-2024 ($ Millions)
Figure 77. South Africa Opioids Revenue Growth 2019-2024 ($ Millions)
Figure 78. Israel Opioids Revenue Growth 2019-2024 ($ Millions)
Figure 79. Turkey Opioids Revenue Growth 2019-2024 ($ Millions)
Figure 80. GCC Country Opioids Revenue Growth 2019-2024 ($ Millions)
Figure 81. Manufacturing Cost Structure Analysis of Opioids in 2023
Figure 82. Manufacturing Process Analysis of Opioids
Figure 83. Industry Chain Structure of Opioids
Figure 84. Channels of Distribution
Figure 85. Global Opioids Sales Market Forecast by Region (2025-2030)
Figure 86. Global Opioids Revenue Market Share Forecast by Region (2025-2030)
Figure 87. Global Opioids Sales Market Share Forecast by Type (2025-2030)
Figure 88. Global Opioids Revenue Market Share Forecast by Type (2025-2030)
Figure 89. Global Opioids Sales Market Share Forecast by Application (2025-2030)
Figure 90. Global Opioids Revenue Market Share Forecast by Application (2025-2030)
